| Code | 3221E | ||||||||
| MA number | 12/0067/23-S | ||||||||
| Product Form: | dis ijf 2x10 ml/500 mg (liek.inj.skl.) | ||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||
| Type of procedure: | Decentralised | ||||||||
| MAH, country: | Sandoz Pharmaceuticals d.d., Slovenia | ||||||||
| Therapeutic Class: | 12 - ANTIANAEMICA | ||||||||
| ATC: |
|
||||||||
| Shelf life: | 24 | ||||||||
| Container: | glass vial | ||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 04.04.2023 |
| Validity: | 04.04.2028 |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Ferric carboxymaltose Sandoz_dis ijf_07_2024.pdf
|
| SPC: |
SPC_Ferric carboxymaltose Sandoz_dis ijf_07_2024.pdf
|
| Safety feature | Yes |
| Data update: | 09.11.2023 |
